Lantheus Holdings, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Lantheus Holdings, Inc. (LNTH) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $33.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $33.45M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $50.17M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $16.52M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $15.94M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $33.45M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $50.17M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $16.52M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $15.94M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $24.05M 10-Q · filed 2025-05-07 |
| 2024-09-30 | $11.84M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $22.74M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $29.80M 10-Q · filed 2024-05-02 |
| 2023-09-30 | $11.30M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $24.12M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $31.62M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $8.31M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $16.62M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $24.92M 10-Q · filed 2022-04-29 |
| 2021-09-30 | $8.37M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $16.75M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $14.05M 10-Q · filed 2021-05-04 |
| 2020-09-30 | $4.77M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.53M 10-Q · filed 2020-07-31 |
| 2016-09-30 | $1.28M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $2.59M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $3.88M 10-Q · filed 2016-05-03 |
| 2015-09-30 | $1.47M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $2.99M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |